Characterization of Human Duodenal Fluids in Fasted and Fed State Conditions.

This work provides an elaborate characterization of human intestinal fluids (HIF) collected in fasted- and fed-state conditions. HIF from 20 healthy volunteers (10 M/F) were aspirated by intubation near the ligament of Treitz in a time-dependent manner (10-min intervals) and characterized for pH, bile salts, phospholipids, cholesterol, triacylglycerides (TAG), diacylglycerides (DAG), monoacylglycerides (MAG), free fatty acids (FFA), pancreatic lipase, phospholipase A2, and nonspecific esterase activity. For almost all parameters, a food-induced effect was observed. Results were characterized by a high variability, as illustrated by the broad ranges observed for each parameter: pH (fasted: 3.4-8.3; fed: 4.7-7.1), bile salts (fasted: 0.03-36.18 mM; fed: 0.74-86.14 mM), phospholipids (fasted: 0.01-6.33 mM; fed: 0.16-14.39 mM), cholesterol (fasted: 0-0.48 mM; fed: 0-3.29 mM), TAG (fed: 0-6.76 mg/mL), DAG (fed: 0-3.64 mg/mL), MAG (fasted: 0-1.09 mg/mL; fed: 0-11.36 mg/mL), FFA (fasted: 0-3.86 mg/mL; fed: 0.53-15.0 mg/mL), pancreatic lipase (fasted: 26-86 g/mL; fed: 146-415 g/mL), phospholipase A2 (fasted: 3-6 ng/mL; fed: 4.3-27.7 ng/mL), and nonspecific esterase activity (fasted: 270-4900 U/mL; fed: 430-4655 U/mL). This comprehensive overview may serve as reference data for physiologically based pharmacokinetic modeling and the optimization of biorelevant simulated intestinal fluids for the use in in vitro dissolution, solubility, and permeability profiling.

[1]  N. Hellmann,et al.  Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development. , 2015, Journal of pharmaceutical sciences.

[2]  J. Tack,et al.  Intestinal behavior of the ester prodrug tenofovir DF in humans. , 2015, International journal of pharmaceutics.

[3]  Clive G. Wilson,et al.  Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  J. Dressman,et al.  Composition and physicochemical properties of fasted-state human duodenal and jejunal fluid: a critical evaluation of the available data. , 2014, Journal of pharmaceutical sciences.

[5]  M. Corsetti,et al.  Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  Christel A. S. Bergström,et al.  Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  P. Annaert,et al.  A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  Martin Bergstrand,et al.  PBPK models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  A. Mohammed,et al.  The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs. , 2013, International journal of pharmaceutics.

[10]  A. Müllertz,et al.  Bile salts and their importance for drug absorption. , 2013, International journal of pharmaceutics.

[11]  C. Porter,et al.  Lipid Absorption Triggers Drug Supersaturation at the Intestinal Unstirred Water Layer and Promotes Drug Absorption from Mixed Micelles , 2013, Pharmaceutical Research.

[12]  Carson C. Chow,et al.  A new method for determining gastric acid output using a wireless pH‐sensing capsule , 2013, Alimentary pharmacology & therapeutics.

[13]  T. Koch,et al.  Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs. , 2013, Biochemical pharmacology.

[14]  C. Reppas,et al.  Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of danazol across Caco-2 cell monolayers. , 2012, Molecular pharmaceutics.

[15]  K. Goumas,et al.  Precipitation in and Supersaturation of Contents of the Upper Small Intestine After Administration of Two Weak Bases to Fasted Adults , 2011, Pharmaceutical Research.

[16]  F. Lammert,et al.  Equilibrium drug solubility measurements in 96-well plates reveal similar drug solubilities in phosphate buffer pH 6.8 and human intestinal fluid. , 2011, International journal of pharmaceutics.

[17]  A. Müllertz,et al.  Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies , 2010, The Journal of pharmacy and pharmacology.

[18]  Kayoko Ohura,et al.  The role of intestinal carboxylesterase in the oral absorption of prodrugs. , 2010, Current drug metabolism.

[19]  G. Duchateau,et al.  Postprandial Changes in Solubilizing Capacity of Human Intestinal Fluids for BCS Class II Drugs , 2009, Pharmaceutical Research.

[20]  P Augustijns,et al.  Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states. , 2009, Journal of pharmaceutical sciences.

[21]  J. Tack,et al.  Parallel Monitoring of Plasma and Intraluminal Drug Concentrations in Man After Oral Administration of Fosamprenavir in the Fasted and Fed State , 2007, Pharmaceutical Research.

[22]  M. Armand Lipases and lipolysis in the human digestive tract: where do we stand? , 2007, Current opinion in clinical nutrition and metabolic care.

[23]  C. Porter,et al.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.

[24]  J. Dressman,et al.  Characterization of the Human Upper Gastrointestinal Contents Under Conditions Simulating Bioavailability/Bioequivalence Studies , 2006, Pharmaceutical Research.

[25]  P. Hellström,et al.  The physiology of gastric emptying. , 2006, Best practice & research. Clinical anaesthesiology.

[26]  Patrick Augustijns,et al.  Characterization of fasted‐state human intestinal fluids collected from duodenum and jejunum , 2006, The Journal of pharmacy and pharmacology.

[27]  H. Lennernäs,et al.  A Clinical Single-Pass Perfusion Investigation of the Dynamic in Vivo Secretory Response to a Dietary Meal in Human Proximal Small Intestine , 2006, Pharmaceutical Research.

[28]  Hans Lennernäs,et al.  The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids , 2005, Pharmaceutical Research.

[29]  J. Keller,et al.  Human pancreatic exocrine response to nutrients in health and disease , 2005, Gut.

[30]  R. Lehner,et al.  Techniques to measure lipase and esterase activity in vitro. , 2005, Methods.

[31]  H. Kristensen,et al.  Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[32]  A. Nagao,et al.  Phospholipids affect the intestinal absorption of carotenoids in mice , 2003, Lipids.

[33]  C. Luscombe,et al.  Bile Salt/Lecithin Mixed Micelles Optimized for the Solubilization of a Poorly Soluble Steroid Molecule Using Statistical Experimental Design , 2003, Drug development and industrial pharmacy.

[34]  M. Kushiro,et al.  Lysophosphatidylcholine enhances carotenoid uptake from mixed micelles by Caco-2 human intestinal cells. , 2001, The Journal of nutrition.

[35]  S. Noh,et al.  Phosphatidylcholine inhibits and lysophosphatidylcholine enhances the lymphatic absorption of alpha-tocopherol in adult rats. , 2001, The Journal of nutrition.

[36]  D. M. Amundson,et al.  Fluorometric method for the enzymatic determination of cholesterol. , 1999, Journal of biochemical and biophysical methods.

[37]  A. Mäkelä,et al.  Duodenal secretion of phospholipase A2, amylase, and bicarbonate in chronic pancreatitis , 1998, Journal of Gastroenterology.

[38]  J. Dressman,et al.  Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. , 1997, Journal of pharmaceutical sciences.

[39]  J. Calbet,et al.  Role of caloric content on gastric emptying in humans. , 1997, The Journal of physiology.

[40]  D. Lairon,et al.  Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. , 1996, The American journal of physiology.

[41]  P. Sauve,et al.  Intestinal cholesterol uptake: Comparison between mixed micelles containing lecithin or lysolecithin , 1985, Lipids.

[42]  A. Hofmann,et al.  Enzymatic measurement of choline-containing phospholipids in bile. , 1981, Journal of lipid research.

[43]  G. Duchateau,et al.  Plant sterol analysis in relation to functional foods. , 2004 .